van der Poel HG - Search Results

1

Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer.

Bosschieter J, Vis AN, van der Poel HG, Moonen LM, Horenblas S, van Rhijn BWG, Pieters BR, Nieuwenhuijzen JA, Hendricksen K. Bosschieter J, et al. Among authors: van rhijn bwg, van der poel hg. Eur Urol. 2018 Sep;74(3):369-375. doi: 10.1016/j.eururo.2017.05.054. Epub 2017 Jun 12. Eur Urol. 2018. PMID: 28619396

2

Quantitative light microscopy in urological oncology.

van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FM, Schalken JA. van der Poel HG, et al. J Urol. 1992 Jul;148(1):1-13. doi: 10.1016/s0022-5347(17)36494-7. J Urol. 1992. PMID: 1613843 Review. No abstract available.

3

Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.

van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: van stratum p. Urology. 1996 Sep;48(3):357-64. doi: 10.1016/S0090-4295(96)00210-5. Urology. 1996. PMID: 8804485 Free article. Clinical Trial.

4

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

5

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: van balken mr. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

6

Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer.

Witjes JA, van der Poel HG, van Balken MR, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: van balken mr, van der poel hg. Eur Urol. 1998;33(4):387-91. doi: 10.1159/000019621. Eur Urol. 1998. PMID: 9612682

7

The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.

Schamhart DH, de Reijke TM, van der Poel HG, Witjes JA, de Boer EC, Kurth K, Schalken JA. Schamhart DH, et al. Among authors: van der poel hg. Eur Urol. 1998 Aug;34(2):99-106. doi: 10.1159/000019692. Eur Urol. 1998. PMID: 9693243 Clinical Trial.

8

Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.

van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. van der Poel HG, et al. Among authors: van geel an. Eur Urol. 1999;35(3):197-203. doi: 10.1159/000019849. Eur Urol. 1999. PMID: 10072620

9

Markers for recurrence of superficial bladder cancer: what is valid?

van der Poel HG. van der Poel HG. Curr Opin Urol. 1999 Sep;9(5):401-6. doi: 10.1097/00042307-199909000-00006. Curr Opin Urol. 1999. PMID: 10579077 Review.

10

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: van der poel hg. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters